Wilda et al. (2004)
Summary of novel genes
| Entity | Tier 1 genes | Tier 2 genes | Tier 3 genes |
|---|---|---|---|
| BL | 1 | 0 | 0 |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
This study, New Tier 1, 1
New Tier 1, BL Tier 1, 1
This study, New Tier 2, 0
New Tier 2, BL Tier 2, 0
This study, New Tier 3, 0
New Tier 3, BL Tier 3, 0
All other BL studies, BL Tier 1, 31
All other BL studies, BL Tier 2, 72
All other BL studies, BL Tier 3, 70
Novel genes reported in this study
Tier 1
| New gene | BL tier |
|---|---|
| TP53 | 1 |
Details
Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and
W. Woessmann. 2004. “Inactivation of the ARF-MDM-2-p53 Pathway in Sporadic
Burkitt’s Lymphoma in Children.” Leukemia
18 (3): 584–88. https://doi.org/10.1038/sj.leu.2403254.


